Register for email alerts and news feeds:
This journal | BMJ Group
rss
Journal of Medical Ethics 2008;34:690-694; doi:10.1136/jme.2006.018564
Copyright © 2008 by the BMJ Publishing Group Ltd & Institute of Medical Ethics.

Research ethics

Genetic research on rare familial disorders: consent and the blurred boundaries between clinical service and research

1 Centre for Family Research, University of Cambridge, Cambridge, UK
2 Public Health Sciences, University of Edinburgh, Edinburgh, UK
3 Department of Medical Genetics, Cambridge Institute for Medical Research, Addenbrookes Hospital, Cambridge, UK

Correspondence to:
Mrs M Ponder, Centre for Family Research, University of Cambridge, Free School Lane, Cambridge CB2 3RF, UK; map1000{at}cam.ac.uk

Objectives: To study the consent process experienced by participants who are enrolled in a molecular genetic research study that aims to find new genetic mutations responsible for an apparently inherited disorder.

Design: Semi-structured interviews and analysis/description of main themes.

Participants: 78 members of 52 families who had been recruited to a molecular genetic study.

Results: People were well informed about the goals, risks and benefits of the genetic research study but could not remember the consent process. They had mostly been recruited to take part by trusted clinicians or their relatives but had little memory of, or concern about signing consent forms. Families appeared to regard the research as a continuation of their, or their relatives’, clinical care.

Conclusions: Ethical review should be more flexible in its attitude to consent forms and written information sheets for some sorts of research. For rare genetic disease studies where research has been discussed fully within the clinical setting then the consent obtained at that time could suffice rather than needing extra consent at a later stage. However, clinician-researchers will need to ensure that their duty of care extends for the duration of the research and beyond.

Keywords: documented consent; research ethics; genetic research; rare diseases


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Raymond, F. L., Whibley, A., Stratton, M. R., Gecz, J. (2009). Lessons learnt from large-scale exon re-sequencing of the X chromosome. Hum Mol Genet 18: R60-R64 [Abstract] [Full Text]  
  • Hallowell, N, Cooke, S, Crawford, G, Parker, M, Lucassen, A (2009). Healthcare professionals' and researchers' understanding of cancer genetics activities: a qualitative interview study. J. Med. Ethics 35: 113-119 [Abstract] [Full Text]  

eLetters:

Read all eLetters

Information sheets for research
Hugh Davies
JME Online, 10 Sep 2008 [Full text]

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.